 | | Vol. 14.16 – 25 April, 2023 |
| |
|
|
| This Phase III study was designed to compare the safety and efficacy of motixafortide + granulocyte colony-stimulating factor (G-CSF) versus placebo + G-CSF in patients with multiple myeloma undergoing hematopoietic stem progenitor cell mobilization before autologous hematopoietic stem cell transplantation.
[Nature Medicine] |
|  |
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Investigators showed that obesity was highly associated with CHIP and that a pro-inflammatory state could potentiate the progression of CHIP to more significant hematologic neoplasia.
[Journal Of Clinical Investigation] |
|
|
|
| Researchers examined immune responses in genetically distinct models of AML and demonstrated that specific AML oncogenes dictate immunogenicity, the quality of immune response, and immune escape through immunoediting.
[Nature Communications] |
|
|
|
| Scientists showed that AML-derived macrophages presented immunosuppressive and pro-leukemogenic functions, in part related to the acquisition of AML mutations.
[Science Advances] |
|
|
|
| Investigators reported pre-clinical single-agent activity of 753B against different leukemia subsets. 753B effectively reduced cell viability and induced dose-dependent degradation of BCL-XL and BCL-2 in a subset of hematopoietic cell lines, AML primary samples, and in vivo PDX AML model.
[Haematologica] |
|
|
|
| Researchers tested whether reticulocytes in donor RBC units could enhance RBC alloimmunization. Using a murine model, they demonstrated that transfusing donor RBC units with increased reticulocyte frequencies dose-dependently increased RBC alloimmunization rates and alloantibody levels.
[Haematologica] |
|
|
|
| Investigators characterized and quantified fetal megakaryocytic cells in mouse fetal liver according to their glycan residues at different gestational ages through lectins.
[Scientific Reports] |
|
|
|
| Researchers provided insights into the transcriptomic features of TMEM173 in the bone marrow of high-risk B cell acute lymphoblastic leukemia (B-ALL) patients. Targeted activation of TMEM173 in specific cells might provided new therapeutic strategies for B-ALL patients.
[BMC Cancer] |
| |
|
|
| Scientists reported the results of a retrospective analysis on second allogeneic transplantation treated with total marrow irradiation as a myeloablative conditioning regimen, intending to limit toxicity.
[Transplantation And Cellular Therapy] |
|
|
|
|
| The authors update knowledge regarding the diagnosis and severity assessment of sinusoidal obstruction syndrome, also known as veno-occlusive disease in adult patients, and also its pathophysiology and treatment.
[Bone Marrow Transplantation] |
|
|
|
|
| ALX Oncology Holdings Inc. announced it has entered into a clinical trial collaboration and supply agreement with Sanofi to evaluate the combination of Evorpacept, a CD47 blocker, and SARCLISA, for the treatment of patients with relapsed or refractory multiple myeloma.
[ALX Oncology Holdings, Inc.] |
|
|
|
|
|
|
|
| | University of Texas Health Science Center – San Antonio, Texas, United States |
|
|
|
| | University Medical Center Groningen – Groningen, Netherlands |
|
|
|
| | University of Reading – Reading, England, United Kingdom |
|
|
|
| | Sanquin Blood Supply – Amsterdam, Netherlands |
|
|
|
| | Case Western Reserve University – Cleveland, Ohio, United States |
|
|
|
|
Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell News
